drugset / Trial / NCT01833390
MagniXene MRI Use in Patients With Asthma and COPD to Assess Regional Lung Function by Delineating Ventilation Defects
Phase 2
Completed
58 enrolled
Xemed LLC
National Heart, Lung, and Blood Institute (NHLBI) · collabNational Institutes of Health (NIH) · collabUniversity of Virginia · collab
NaSingle-groupOpen-labelDiagnostic
Summary
The purpose of this clinical trial is to demonstrate hyperpolarized xenon (HXe) as a medical imaging drug (agent) for Magnetic Resonance Imaging (MRI) of the human lung ventilation.
Timeline
- Start
- 2011-09
- Primary completion
- 2015-01
- Completion
- 2015-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MagniXene | Diagnostic / imaging agent | 1000 ml | Inhaled |